Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ventas, Inc. (VTR): Why Not Only Old-Timers Should Be Interested In This Specialty REIT

–Acquisitions: In July 2011, Ventas, Inc. (NYSE:VTR) acquired Nationwide Health Properties Incorporated; further acquisitions could add quality properties to the company’s portfolio and drive revenue growth
–Gaining Further Market Share of Enormous Healthcare Real Estate Market: The healthcare real estate market is estimated to be worth more than $1 trillion, leaving plenty of room for Ventas to expand into this massive market which they currently possess so little a share of

Threats:

–Rising Interest Rates: Ventas, Inc. (NYSE:VTR) consistently has utilized the record low interest rates to take out loans to fund expansion plans and acquisitions, however any rise in these rates could hinder the company’s growth prospects and threaten business

Competitors:

Major publicly traded competitors of Ventas include Health Care REIT, Inc. (NYSE:HCN), HCP, Inc. (NYSE:HCP), Brookdale Senior Living, Inc. (NYSE:BKD), and Senior Housing Properties Trust (NYSE:SNH). All of these companies operate in the health care real estate industry and compete directly against Ventas.

Health Care is valued at $18.05 billion, pays out a dividend yielding 4.88%, and carries a price to earnings ratio of 254.36. Health Care possesses a price to book ratio of 1.89. Fundamentally, the company’s business model is profitable, with a TTM profit margin of 15.29%. Into the future, Health Care is anticipated to grow revenue and earnings in the low-single digit range.

HCP is valued at $19.09 billion, pays out a dividend yielding 5.00%, and carries a price to earnings ratio of 21.56. HCP possesses a price to book ratio of 1.97. Fundamentally, the company’s business model is extremely solid, with a TTM profit margin of 44.29%. Flat line growth is projected through 2015 for the company in terms of revenue.

Brookdale is valued at $3.26 billion, does not pay out a dividend, and carries a negative price to earnings ratio. Brookdale presently carries a price to book ratio of 3.47. Fundamentally, the company’s business model is weak, with a TTM profit margin of -1.85%. In respect to revenue, the company is projected to sustain steady low single digit growth into the future.

Senior Housing is valued at $4.62 billion, pays out a dividend yielding 6.35%, and carries a price to earnings ratio of 30.91. The company possesses a price to book ratio of 1.74. Fundamentally, Senior Housing’s business model is strong, with a TTM profit margin of 20.13%. Looking into the future, Senior Housing is anticipated to experience choppy revenue growth into 2015.

The Foolish Bottom Line:

Financially, Ventas, Inc. (NYSE:VTR) is extremely solid with disregard to its rather substantial debt position. The company possesses stable revenue growth, a growing dividend, and a diversified portfolio of properties. The company’s weaknesses include its high valuation and large exposure to rising interest rates. Looking forward, the company is likely to derive growth from investments it makes into increasing its property count. All in all, Ventas possesses an extremely predictable and stable business model, and should provide investors with solid and stable returns for years to come, however investors should wait for interest rates to stabilize before investing.

The article Why Not Only Old-Timers Should Be Interested In This Specialty REIT originally appeared on Fool.com.

Ryan Guenette has no position in any stocks mentioned. The Motley Fool recommends Health Care REIT. Ryan is a member of The Motley Fool Blog Network — entries represent the personal opinion of the blogger and are not formally edited.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.